123 related articles for article (PubMed ID: 29805561)
1. Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer.
Duan S; Yin J; Bai Z; Zhang Z
Oncol Lett; 2018 Jun; 15(6):8287-8294. PubMed ID: 29805561
[TBL] [Abstract][Full Text] [Related]
2. Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.
Liu L; Bai Z; Ma X; Wang T; Yang Y; Zhang Z
Exp Ther Med; 2016 Mar; 11(3):846-852. PubMed ID: 26998002
[TBL] [Abstract][Full Text] [Related]
3. Expression of taxol resistance gene 1 correlates with gastric cancer patient clinical outcome and induces taxol resistance.
Bai ZG; Qu X; Han W; Ma XM; Zhao XM; Zhang ZT
Mol Med Rep; 2010; 3(6):1071-8. PubMed ID: 21472357
[TBL] [Abstract][Full Text] [Related]
4. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
5. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
[TBL] [Abstract][Full Text] [Related]
6. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
[TBL] [Abstract][Full Text] [Related]
7. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
Xu HB; Shen FM; Lv QZ
Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1.
Bai Z; Zhang Z; Qu X; Han W; Ma X
Oncol Lett; 2012 Jan; 3(1):135-140. PubMed ID: 22740869
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib enhanced the cytotoxic effect of cisplatin in chemo-resistant gastric cancer xenograft mouse models through a cyclooxygenase-2-dependent manner.
Xu HB; Shen FM; Lv QZ
Eur J Pharmacol; 2016 Apr; 776():1-8. PubMed ID: 26879869
[TBL] [Abstract][Full Text] [Related]
11. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203.
You HY; Xie XM; Zhang WJ; Zhu HL; Jiang FZ
In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):857-63. PubMed ID: 27142767
[TBL] [Abstract][Full Text] [Related]
12. Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer.
Kou Y; Tong B; Wu W; Liao X; Zhao M
Front Pharmacol; 2020; 11():616251. PubMed ID: 33362566
[TBL] [Abstract][Full Text] [Related]
13. The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1.
Sun MY; Wang DD; Sun J; Zhao XH; Cai S; Wu QX; Jie T; Ni ZH; Sun JY; Tang QF
Chin J Nat Med; 2019 Mar; 17(3):198-208. PubMed ID: 30910056
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a.
He J; Qi H; Chen F; Cao C
Oncol Lett; 2017 Nov; 14(5):6097-6102. PubMed ID: 29113252
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
17. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.
Chen Z; Chai Y; Zhao T; Li P; Zhao L; He F; Lang Y; Qin J; Ju H
J Cell Physiol; 2019 May; 234(5):5904-5914. PubMed ID: 30488440
[TBL] [Abstract][Full Text] [Related]
18. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
